Milestone Pharmaceuticals (MIST) PE Ratio: History & Chart

Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.

The P/E ratio is N/A as of 2026-10-06T20:37:20.822Z.

Stored calculation inputs

Calculation as of: 2026-10-06T20:37:20.822Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Quote price: 0.7642
Unrounded diluted TTM EPS · period ending 2026-06-30: -0.69

FMP input reference: fb4a8502ebbb15e11e68a15a33f7d53c7b5c9812bb79594c7d74d11368e8432a

Forward PE Ratio|PEG Ratio|P/B Ratio|EPS|All Metrics

MIST PE Ratio Metrics

PE RATIO

N/A

MIST Competitors' PE Ratio

MIST

Milestone Pharmaceuticals Inc.

Current

Market Cap

$95.14M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PARK

Park Dental Partners, Inc. Common Stock

vs MIST

Market Cap

$93.96M

PE Ratio

N/A

TTM Avg

13.33

3Y Avg

13.33

5Y Avg

13.33

KRRO

Korro Bio, Inc.

vs MIST

Market Cap

$97.14M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PYPD

PolyPid Ltd.

vs MIST

Market Cap

$97.90M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNXU

Conexeu Sciences Inc.

vs MIST

Market Cap

$97.94M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OKUR

OnKure Therapeutics, Inc.

vs MIST

Market Cap

$99.62M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RLYB

Rallybio Corporation

vs MIST

Market Cap

$90.64M

PE Ratio

2.19

TTM Avg

2.16

3Y Avg

2.16

5Y Avg

2.16

BMEA

Biomea Fusion, Inc.

vs MIST

Market Cap

$90.37M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ICCC

ImmuCell Corporation

vs MIST

Market Cap

$90.20M

PE Ratio

117.85

TTM Avg

46.83

3Y Avg

44.28

5Y Avg

282.12

EQ

Equillium, Inc.

vs MIST

Market Cap

$89.78M

PE Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PE RATIO	TTM	3Y	5Y
Milestone Pharmaceuticals Inc. (MIST)	$95.14M	N/A	N/A	N/A	N/A
Park Dental Partners, Inc. Common Stock (PARK)vs ›	$93.96M	N/A	13.33	13.33	13.33
Korro Bio, Inc. (KRRO)vs ›	$97.14M	N/A	N/A	N/A	N/A
PolyPid Ltd. (PYPD)vs ›	$97.90M	N/A	N/A	N/A	N/A
Conexeu Sciences Inc. (CNXU)vs ›	$97.94M	N/A	N/A	N/A	N/A
OnKure Therapeutics, Inc. (OKUR)vs ›	$99.62M	N/A	N/A	N/A	N/A
Rallybio Corporation (RLYB)vs ›	$90.64M	2.19	2.16	2.16	2.16
Biomea Fusion, Inc. (BMEA)vs ›	$90.37M	N/A	N/A	N/A	N/A
ImmuCell Corporation (ICCC)vs ›	$90.20M	117.85	46.83	44.28	282.12
Equillium, Inc. (EQ)vs ›	$89.78M	N/A	N/A	N/A	N/A

P/E Comparison

Trailing P/E

N/A

Forward P/E

N/A

Forward P/E Calculation

View All Analyst Estimates

Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.

Calculation:

Current Price

$0.76

÷

Forward EPS (Est.)

$-0.84

=

Forward P/E

N/A

Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.

PE Ratio Formula & Definition

PE Ratio = Share Price / Diluted EPS (TTM)

The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

See the Lowest P/E Ratio Stocks ranking →

PE Ratio: N/A

MIST PE Ratio Metrics

MIST Competitors' PE Ratio

P/E Comparison

Forward P/E Calculation

PE Ratio Formula & Definition

Related Metrics